Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|November 21, 2012
Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonistsAntonella Bugatti, Cinzia Giagulli, Chiara Urbinati, et al.
Biomaterials|February 9, 2016
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected miceManuela Donalisio, Paola Quaranta, Flavia Chiuppesi, et al.
European Journal of Medicinal Chemistry|September 24, 2020
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assaysAlice Parodi, Giada Righetti, Emanuela Pesce, et al.
Nanoscale Advances|September 14, 2023
Surface functionalization of extracellular vesicle nanoparticles with antibodies: a first study on the protein corona "variable"Angelo Musicò, Rossella Zenatelli, Miriam Romano, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2013
Multispot, label-free biodetection at a phantom plastic-water interfaceFabio Giavazzi, Matteo Salina, Roberto Cerbino, et al.
Free Radical Biology & Medicine|November 6, 2012
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3Alessandro Matte, Mariarita Bertoldi, Narla Mohandas, et al.
Plos One|October 12, 2013
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histoculturesIsabella Bon, David Lembo, Marco Rusnati, et al.
Biochemistry|August 14, 2002
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitorsBenito Casu, Marco Guerrini, Annamaria Naggi, et al.
The International Journal of Biochemistry & Cell Biology|November 13, 2007
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domainBarbara Margosio, Marco Rusnati, Katiuscia Bonezzi, et al.
International Journal of Molecular Sciences|October 27, 2022
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and RescuingPaola Fossa, Matteo Uggeri, Alessandro Orro, et al.
Pageof 10